Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting

NARecruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Cardiovascular Diseases (CVD)
Interventions
BEHAVIORAL

Heart Age

Heart Age is the phenotypic age based on the risk of the patient participant using a modified tool for CVD risk from the Framingham risk Score. The Heart Age is the age at which an individual would be expected to develop CVD in the next ten years relative to another individual of the same sex and age if all the current CVD risk factors were to be eliminated.

BEHAVIORAL

Heart Age-HOPE-CVD App

Patient participants will use an online mobile, evidence-based behavioural change psychoeducation application for 24 weeks. New psychoeducational content is released every week. The first seven weeks of the programme seeks to resolve ambivalence about initiating a lifestyle change and increase the readiness and motivation to change. Between Weeks 8 and 15, the platform will support action planning and guide users to execute their preferred self-care behaviour safely and effectively. The remaining nine weeks will provide the user with the skills that will help them with coping and planning to manage relapses and temptations.

BEHAVIORAL

Communication of Genetic Risk Score

General practitioners will draw 3ml of blood from each patient participant for analysis of the patient's genetic risk score of having cardiovascular disease. This genetic risk score will be communicated to the patient, and the communication will include informing patients what cardiovascular disease genetic risk is, what their genetic risk category compared to the population in Singapore is, and what their score means for the future.

Trial Locations (1)

Unknown

RECRUITING

Lee Kong Chian School of Medicine, NTU, Singapore

All Listed Sponsors
collaborator

National University of Singapore

OTHER

collaborator

National University Health System, Singapore

OTHER

lead

Nanyang Technological University

OTHER